The data collected based on
15
patient reviews on Google
Certificates
Features & Facts
Therapy for Different Cancers
From 2020 to 2023, Immucura treatment was applied for various types of cancer, including colorectal cancer, which accounted for 11% of cases. Other common cancers included brain and central nervous system (13%), breast (22%), pancreas (10%), and prostate (8%).
Facts in Numbers
Over 1,000 patients have evaluated the benefits of treatment at Immucura and received excellent results. As more patients trust innovative therapy, the annual number of services provided increases permanently.
Numerous Advantages
Treatment at Immucura has significant advantages over long-standing methods such as radiation, chemotherapy, or surgery. First, the absence of pain, lack of side effects, and naturalness of the therapy attract patients worldwide.
Prostate Cancer in Numbers
Stage 4 makes up almost 78% of all prostate cancers treated with Immucura. Regardless of advanced stages, patient survival rates are 100% within the first year of treatment, 83% after 3 years, 80% after 5 years, and 50% after 10 years.
Comprehensive Solution
Doctors have developed a cancer defense pack program to restore metabolic processes. Specific trace elements can reduce the manifestations of mitochondrial dysregulation in cancer cells, significantly improving the efficacy of dendritic cell therapy.
Breast Cancer Under Control
Given breast cancer survival rates, Immucura's data is promising. During the 11-year cure period, all patients survived, demonstrating a 100% survival rate. After 3 years, the indicator is 88%; after 5 years, 79%. Almost 77% of patients have stage 4 cancer, and 79% have metastases.
Latest Treatment Applications
Although dendritic cells were discovered in the 19th century, their ability to destroy cancer cells was not recognized until 2011. Despite the treatment's novelty,ty more than 700,000 clinical articles have already been published.
Promising Results for Brain Cancer
Even though a large number of treatments with dendritic cells are stage 4, the survival rate for brain cancer in the company is relatively high. In particular, the rate is 69% after 1 year, 45% after 3 years, and 27% after 5 years.
Powerful Protection
Immucura has learned to fully harness the potential of dendritic cell therapy, which can produce approximately 40 to 60 billion protective cells per day. Killer cells can identify a malignant cell before it multiplies and causes irreparable damage to health.
Stage 4 has a Chance
Analysis of the company's statistics over the last few years showed that the survival rate of patients with stage 4 colorectal cancer after treatment was 100% within the first year, 60% within three years, and 25% after 5 years. This indicator is much higher than that of standard cure methods.
The Sooner, the Better
Immucura works with highly complex cases of esophageal cancer and has had statistics for several years. The 1-year survival rate for stage 4 was 40%, and after 2 years, it was 20%. The earlier the treatment is started, the greater the chances of success.
Without Fear of Difficulties
Although more than 90% of pancreatic cancer treated with Immucura is stage 4 in an advanced form, the innovative treatment gives patients a survival rate of almost 42% during the first year. Further research on dendritic cell therapy could be revolutionary.
About the clinic
Immucura is a world-renowned healthcare service provider for new cancer treatments, including experimental and innovative solutions, and a leader in dendritic cell therapy (DCT). Since 2014, it has used an innovative approach to treating oncological lesions. By targeting the causes and mechanisms of cancer, not just its effects, Immucura has decisive advantages over conventional treatments. The approach of Immucura specialists is a holistic strategy for oncology treatment, consisting of the most natural fight against cancer, DCT, and additional counseling on nutrition, lifestyle, sleep, breathing sessions, and psychological support. The company's concept is that a healthy person can produce up to 150,000 cancer cells, which are under the immune system's control and are effectively destroyed. Therefore, oncological disorders develop precisely because of the dysregulation of immune processes and a decreased protective effect. Dendritic cell therapy (DCT) can be considered a natural immunotherapy that allows you to treat oncological lesions without introducing pharmaceuticals, chemicals, or external interventions. This approach is much safer and more effective than radiation or chemotherapy. In addition, using the patient's cells and the body's own capabilities makes the cure completely personalized and unique. The DCT procedure is straightforward and involves drawing a 60-180 ml venous blood sample. Dendritic cells will be cultured from the blood monocytes in a unique laboratory for several weeks. Dendritic cells help the immune system recognize and attack abnormal cells. After mature dendritic cells are introduced into the body, the immune system mounts a strong response against malignant cells and learns to fight them within 6-9 months. Immune memory transmitter therapy (IMT) can be combined with dendritic cell therapy to enhance immunological memory and effectiveness. In addition, Immucura specializes in nanothermia, or modulated electro-hyperthermia (mEHT), a painless anticancer therapy with high efficacy, enabled by radio frequencies that penetrate deep into tissue layers and by the high conductivity of malignant tissues. Activation of the p53 tumor suppressor protein helps suppress the activity of malignant tissues and facilitates their natural death (apoptosis). With innovative oncological solutions, the team offers a precise diagnostic targeted specifically for cancer patients. The team has a dedicated Immucura Diagnostics division, a leader in preventive cancer diagnostics specializing in innovative, noninvasive early-detection solutions. Among the services are deep blood analysis, genetic cancer test, liquid biopsy, proteome analysis, thermocheck (female breast scan), and personalized medical consultations. Numerous positive reviews of the Immucura tea, with well-deserved treatment efficiency results, are well-deserved. A comprehensive approach to each patient, a thorough analysis of the body's condition, and an understanding of the impact on the various causes of cancer, using the latest medical discoveries in Cancer Health, are the drivers of success. The availability of treatment across different countries indicates special care and understanding of patients' needs.
Each treatment plan is discussed individually, and the duration may depend on the presence of concomitant chemotherapy. Generally, growing cells in the laboratory takes 9-21 days after blood sampling.
Should I stop my primary cancer treatment using dendritic cell therapy?
Unlike chemotherapy, cellular immunotherapy is a primary therapy, not just an adjunctive therapy. Also, dendritic cell therapy is well combined with traditional treatment methods. Exclusion or abandonment is accepted after individual consultation.
If I am unable to travel, can I be treated at home?
Immucura's services cover Europe, offering home flying nurses, online consultations, and collaboration with clinics in the UK, Germany, Austria, Croatia, and the Netherlands. With a well-structured logistics network, Immucura can reach and help patients in many countries.
Can I contact the company for an oncology check-up?
Immucura provides services for early cancer diagnosis and for checking everyone's current cancer status. A unique, specially developed program that allows doctors to detect malignant lesions at their earliest stages is used by world leaders.
The clinic has 15 feedbacks at other places. The UserScore of the hospital is 65%.
How can you book a service, and what is the cost?
There are 9 price tags presented on AiroMedical. Select the service needed and proceed with booking. Don’t find a proper deal, contact the clinic to get a custom offer.
What is the overall experience of the facility?
Immucura has been operating since 2014. It has accumulated over 12 years of clinical background.
Where can I see the hospital's work, interior space, and exterior?
